Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 3Breast 3Thoracic 1Sarcoma 1Other solid neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Breast Neoplasms 3Fasting 2Ovarian Neoplasms 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Angptl4 protein, mouse × Breast × Clear all
NCT06536881 2025-08-17

GAMMER

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting
30 enrolled
Breast

Breast Neoplasms

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown
150 enrolled
BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

NCT04330339 2022-07-21

Prolonged Nightly Fasting in Breast Cancer Survivors

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Breast

Breast Neoplasms, Fasting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡